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Abstract   
 
Salmonellosis is one of the most important bacterial zoonotic diseases in humans and Salmonella 
infections are often linked with the consumption of contaminated pork. In order to reduce Salmonella 
Typhimurium infections in humans, minimization of the Salmonella intake into the food chain is 
important. Vaccination has been proposed to control Salmonella infections in pigs. However, pigs 
vaccinated with the current vaccines cannot be discriminated from infected pigs with the 
lipopolysaccharide (LPS) -based serological tests used in European serosurveillance programmes. We 
therefore examined which LPS encoding genes of Salmonella Typhimurium can be deleted to allow 
differentiation of infected and vaccinated pigs, without affecting the vaccine strain’s protective 
capacity. For this purpose, deletion mutants in Salmonella strain 112910a, used as vaccine strain, were 
constructed in the LPS encoding genes: ∆rfbA, ∆rfaL, ∆rfaJ, ∆rfaI, ∆rfaG and ∆rfaF. Inoculation of 
BALB/c mice with the parent strain, ∆rfaL, ∆rfbA or ∆rfaJ strains but not the ∆rfaG, ∆rfaF or ∆rfaI 
strains protected significantly against subsequent infection with the virulent Salmonella Typhimurium 
strain NCTC12023. Immunization of piglets with the ∆rfaJ or ∆rfaL mutants resulted in the induction 
of a serological response lacking detectable antibodies against LPS. This allowed a differentiation 
between sera from pigs immunized with the ∆rfaJ or ∆rfaL strains and sera from pigs infected with 
their isogenic wild type strain.  
 
Introduction 
 
Salmonella infections in humans are often linked with the consumption of contaminated pork [1] [2]. 
Vaccination has been proposed to control Salmonella infections in pigs [1] [3] [4] and has already 
proven to be efficient in laying hens, reducing faecal shedding and internal egg contamination [5] [6]. 
Currently, one licensed Salmonella Typhimurium live vaccine for pigs is commercially available in 
Europe [7]. The use of this vaccine is limited due to interference with European Salmonella 
serosurveillance programmes based on the detection of antibodies against the lipopolysaccharides 
(LPS) of Salmonella [8]. It was therefore the aim of this study to develop a DIVA-vaccine strain 
(Differentiation of Infected and Vaccinated Animals), without attenuating the vaccine strain, which 
would not interfere with current LPS-ELISA based serosurveillance programmes.  
 
Material and Methods 
 
Salmonella Typhimurium strain 112910a, phage type 120/ad, isolated from a pig stool sample and 
characterized previously [3], was used as the wild type background to construct several isogenic LPS 
knock-out mutants: ∆rfbA, ∆rfaL, ∆rfaJ, ∆rfaI, ∆rfaG and ∆rfaF. A commercially available enzyme-
linked immunosorbent assay (ELISA) (HerdChek Salmonella; IDEXX Laboratories, Schiphol-Rijk, 
Noord-Holland, The Netherlands) for the detection of porcine antibodies against the LPS of 
Salmonella was used as a reference according to the manufacturer’s instructions. Besides, an in-house 
Salmonella Typhimurium strain 112910a whole cell ELISA to detect porcine anti Salmonella 
Typhimurium antibodies, was prepared as described before [9]. In a mouse model, we tested whether 
the LPS mutants affect the protective capacity of Salmonella Typhimurium strain 112910a against a 
subsequent challenge with a highly virulent strain. For that purpose, seven groups of ten mice were 
inoc  10
7
 CFU/ml of one of the LPS
 
mutant strains (either: 
 2 
∆rfbA, ∆rfaL, ∆rfaJ, ∆rfaI, ∆rfaG or ∆rfaF) or with the wild type Salmonella Typhimurium strain 
112910a. Four weeks after primary inoculation, all mice were challenged with 10
8 
CFU of the virulent 
Salmonella Typhimurium strain NCTC12023Nal
20 
by the orogastric route. In a second in vivo study, 
we examined whether it was possible to discriminate between the serological response induced after 
immunization of pigs with either Salmonella Typhimurium strain 112910a or one of its isogenic 
strains (∆rfaL ∆rfaJ) on the one hand and after infection of pigs with Salmonella Typhimurium strain 
112910a on the other hand. Therefore, 14 piglets were randomly allocated to three vaccinated groups 
(n = 12) and one sham-vaccinated control group (n = 2). Vaccinated animals were intramuscularly 
immunized (2x) with one of the formalin-inactivated Salmonella strains (either: Salmonella 
Typhimurium strain 112910a, ∆rfaJ or ∆rfaL) in Freund’s incomplete adjuvant. To obtain sera from 
Salmonella Typhimurium infected piglets, one experimental group (n = 3) was 
 10
7
 CFU of Salmonella Typhimurium strain 112910aNal
20
.  
 
Results 
 
Vaccination of mice with ∆rfbA, ∆rfaL and ∆rfaJ but not ∆rfaI, ∆rfaG and ∆rfaF protects mice 
against a Salmonella Typhimurium infection:  
Oral immunization of mice with Salmonella Typhimurium strain 112910a, ∆rfbA, ∆rfaL or ∆rfaJ 
induced a significant (P < 0.05) protection against subsequent challenge with NCTC12023Nal
20
 in 
both spleen and liver compared to non immunized control animals. Results are shown in figure 1.   
 
 
 
 
Figure 1: Recovery of Salmonella bacteria from various organs of mice immunized with either Salmonella Typhimurium, one of its isogenic 
LPS mutants or non immunized control animals and subsequently challenged with Salmonella Typhimurium strain NCTC12023Nal20. The 
log10 value of the ratio of CFU per gram sample and standard deviations are given. An asterisk refers to a significant difference with the 
control group (P < 0.05). 
 
 
Pigs, immunized with the ∆rfaL or ∆rfaJ mutant, can be serologically differentiated from 
Salmonella infected animals: 
Results showed no significant seroconversion (P > 0.05) in animals immunized with inactivated ∆rfaJ 
or ∆rfaL strains and in sham-vaccinated control animals (non immunized and non infected animals), 
when using the commercial IDEXX ELISA. Conversely, marked seroconversion occurred in pigs 
immunized with the inactivated Salmonella Typhimurium strain 112910a. Results also illustrate a 
clear differentiation between sera from piglets immunized with the ∆rfaJ strain or ∆rfaL strain and 
sera of pigs infected with their isogenic wild type strain. Anti-Salmonella-antibody titers were detected 
in the serum of all immunized and infected animals, when using the in-house whole cell ELISA. 
Results are illustrated in figure 2.  
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Figure 2: Serological results of pigs immunized with ∆rfaL, ∆rfaJ or Salmonella Typhimurium strain 112910a, control pigs (animals that 
were not immunized and not infected) and pigs infected with Salmonella Typhimurium strain 112910a Nal20. Values are represented as a 
percentage compared to the wild type vaccinated group. We emphasize that these results are based on a small sample size. 
 
Discussion 
 
DIVA vaccines are a recent advance in vaccinology enabling distinction between an animal that is 
seropositive to a particular infectious agent because it has been vaccinated, and one that is seropositive 
because it has been infected with virulent field organisms [10]. Because current Salmonella 
serosurveillance programmes are generally based on detection of antibodies against LPS antigens, we 
selected six LPS genes that might be suitable markers to develop a LPS based DIVA-vaccine. In a 
mouse in vivo experiment we showed that the rfaG and rfaF mutant strains were not able to protect 
BALB/c mice against a subsequent infection with Salmonella Typhimurium NCT12023Nal
20
 and that 
the ∆rfaI strain was only able to significantly reduce bacterial counts in the spleen of mice. 
Conversely, ∆rfbA, ∆rfaL and ∆rfaJ strains, with less truncated LPS, were able to successfully protect 
BALB/c mice against a Salmonella Typhimurium infection and their protective capacity was not 
impaired compared to their isogenic wild type strain. These results strongly suggest that a confined 
truncation of LPS is essential to maintain protection against challenge with the virulent strain 
Salmonella Typhimurium NCTC12023Nal
20
 in mice. The ultimate goal of this study was to verify 
whether LPS mutant strains were able to elicit a DIVA humoral immune response in pigs. Our results 
illustrate that both the ∆rfaL and the ∆rfaJ strain gave no seroconversion when using a LPS based 
ELISA, while a clear-cut seroconversion was observed when using an in-house Salmonella 
Typhimurium strain112910a whole cell ELISA. Besides, immunization of piglets with the ∆rfaJ or 
∆rfaL mutants resulted in the induction of a serological response allowing clear differentiation 
between sera from piglets immunized with the ∆rfaJ or ∆rfaL strains and sera of pigs infected with 
their isogenic wild type strain when using a LPS based ELISA.  
 
Conclusion 
 
In conclusion, applying deletions in the rfaJ or the rfaL gene in Salmonella Typhimurium strain 
112910a allows differentiation of infected and vaccinated pigs in an LPS based ELISA without 
reducing the strain’s protective capacities in mice.  
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